SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001354488-13-003942
Filing Date
2013-07-17
Accepted
2013-07-17 13:16:56
Documents
7
Period of Report
2013-08-13
Effectiveness Date
2013-07-17

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A immy_def14a.htm DEF 14A 545676
2 logo.jpg GRAPHIC 5237
3 phone.jpg GRAPHIC 1423
4 detach.jpg GRAPHIC 5279
5 fax.jpg GRAPHIC 1850
6 internet.jpg GRAPHIC 1514
7 mail.jpg GRAPHIC 1326
  Complete submission text file 0001354488-13-003942.txt   570532
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35814 | Film No.: 13972081
SIC: 2834 Pharmaceutical Preparations